COVID-19 Vaccines

← COVID-19 Resources

MOH COVID-19 Vaccine-Related Information and Planning Resources

Quick References

• Q&A for Health Care Providers on Mixed COVID-19 Vaccine Schedules – MOH,  July 16 2021
• AstraZeneca/COVISHIELD COVID-19 Vaccine Second Dose Q&A for Health Care Providers – MOH, June 8, 2021
• “I got AstraZeneca for my first dose. Which vaccine is best for my second?”: one pager | long form – 19 to Zero, June 6, 2021
• Answers to vaccines FAQs: patients and physicians – OCFP, Apr. 29, 2021
• COVID-19: Frequently Asked Questions – NEJM
• Script for patient communication on second dose AstraZeneca vaccines – OCFP, May 21, 2021
• Script for patient communication on AstraZeneca vaccines – OCFP, Apr. 21, 2021
• COVID-19 vaccination information for patients 80-plus – OCFP, Feb. 25, 2021

Special Populations | Allergies

• Myocarditis and pericarditis after mRNA vaccination in children: Interim Guidance | Algorithm – SickKids Hospital, June 30, 2021
• Recommendations on Exceptions to Extended Dose Intervals – Vaccine Clinical Advisory Group, updated May 26, 2021
• COVID-19 Vaccination for Special Populations – OCFP, June 11, 2021 
• COVID-19 Vaccination Recommendations for Special Populations – Ontario MOH, May 27, 2021
• Cancer and COVID-19 Vaccination – infographic
• eConsult Allergy Advice for COVID-19 Vaccine
• COVID-19 Vaccine Adverse Events: Tools for Practice – PEER, June 14, 2021
• COVID-19 Vaccine Screening Form – Ontario MOH, May 21, 2021
• COVID-19 Vaccine Consent Form – Ontario MOH, Jan. 23, 2021
• COVID-19 Vaccine Obtaining Informed Consent - Script for Health Care Providers – Ontario MOH, Dec. 12, 2020/amended Dec. 13, 2020
• Report of Adverse Event Following Immunization Form | Factsheet
• Documentation of Verbal Attestation v.1.0 – Ontario MOH, Feb. 12, 2021
• Documentation of counselling (Allergy form) v.2.0 – Ontario MOH, Feb. 11, 2021 
• Decision Framework for Vaccine in Pregnancy and Breastfeeding  | (related commentary)  – CMAJ, Jan. 2021
• Should I get the COVID-19 vaccine: Decision aid for pregnant and breastfeeding women – PCMCH, April 2021
• Vaccination in Pregnancy & Breastfeeding Decision-Making Support Tool – MOH, April 16, 2021

Vaccination Planning 

• COVID-19 Vaccine-Relevant Information and Planning Resources – Ontario MOH webpage for ongoing updates
• COVID-19 Immunization – A Toolkit for Primary Care Clinics – CovidToolkit.ca (ongoing updates)
• COVID-19 Vaccines – Centre for Effective Practice repository
• COVID-19 Vaccines Toolkit for Health Care Providers – Government of Canada
• COVID-19 Vaccines Toolkit - Communications Resources for Indigenous Communities and Organizations – Government of Canada
• Ontarians want family doctors more fully involved in vaccination (infographic) – OCFP, April 2021.

Vaccine Distribution 

• Guidance for Prioritization of Phase 2 Populations for COVID-19 Vaccination – v. 2.0 – Ontario MOH, April 27, 2021
• Guidance for Prioritizing Health Care Workers for COVID-19 Vaccination v.3.0 – Ontario MOH, Mar. 17, 2021
• COVID-19 Vaccination Distribution Plan ("Placemat" summary graph) – Ontario MOH, as of Feb. 18, 2021
• Sequencing of Phase One Priority Populations – Ontario MOH, Feb. 14, 2021
• COVID-19 Vaccination Update – Ontario MOH, Feb. 2, 2021
• COVID-19 Vaccine Availability and Rollout – Ontario MOH, Dec. 30, 2020
• Ontario Begins Rollout of COVID-19 vaccine  – Ontario MOH news release
• Ontario's Ethical Framework for COVID-19 Vaccine Distribution, Dec. 30, 2020
• Ontario's Vaccine Distribution Implementation Plan – Ontario MOH
• Ontario Ministers’ COVID-19 Vaccine Distribution Task Force
• COVID-19 Vaccines for Ontario – Government of Ontario webpage
• Partnering with Primary Care for Local Rollout in Ontario: A Practical Guide – Primary Care Collaborative 
• About the Ontario Primary Care COVID-19 Vaccination Action Council (PC-VAC) 
• Canada’s COVID-19 Immunization Plan – Globe and Mail / PHAC infographic
• Canada's COVID-19 Immunization Plan – PHAC
• Guidance on the prioritization of initial doses of COVID-19 vaccine(s) – NACI

• Science Brief: Vaccine-Induced Prothrombotic Immune Thrombocytopenia (VIPIT) Following AstraZeneca COVID-19 Vaccination – Science Table COVID-19 Advisory for Ontario
• COVID-19 vaccine approval process and safety – Ontario MOH
• Report of Adverse Event Following Immunization: Form | Factsheet – Public Health Ontario
• How vaccine safety is monitored in Canada – Public Health Ontario
• COVID-19 mRNA vaccines – Health Canada
• Details for Pfizer-BioNTech COVID-19 vaccine – Health Canada
• Administration of the Pfizer-BioNTech COVID-19 vaccine – Ontario MOH
• Administration of the Moderna COVID-19 vaccine – Ontario MOH
• COVID-19 vaccines  – Health Canada webpage
• COVID-19 information, incl. vaccines – PHAC webpage
• Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine – NEJM
• Pfizer-BioNTech COVID-19 vaccine: What you should know – Health Canada
• Health Canada: Drug and vaccine authorizations for COVID-19: List of applications received
• What You Need to Know about the COVID-19 Vaccine for Canada – Government of Canada (two-page summary for the public)
• COVID-19 About Vaccines – Ontario MOH
• COVID-19 Vaccine information sheet: Pfizer-BioNTech and Moderna COVID-19 vaccines – Ontario MOH
• Guidance for the Health Sector – Ontario MOH

 Education

• COVID-19 Vaccination in Canada: An educational series for primary care professionals – UofT DFCM | OCFP (self-learning series of modules)
• COVID-19 Vaccine Foundations for Health Care Providers  – recording of PHAC webinar, Dec. 14, 2020 
• COVID-19 vaccine candidates in development, special focus on mRNA and viral vector platforms – recording of PHAC webinar, Oct. 2020